메뉴 건너뛰기




Volumn 267, Issue 1-2, 2003, Pages 93-100

Enzymatic hydrolysis of diloxanide furoate in the presence of β-cyclodextrin and its methylated derivatives

Author keywords

Cyclodextrin; Diloxanide furoate; Enzymatic hydrolysis; Stability

Indexed keywords

2,3,6 O TRIMETHYL BETA CYCLODEXTRIN; 2,6 O DIMETHYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DILOXANIDE FUROATE; ENZYME; UNCLASSIFIED DRUG;

EID: 0242361229     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.08.003     Document Type: Article
Times cited : (15)

References (20)
  • 1
    • 0031863290 scopus 로고    scopus 로고
    • Enzymatic hydrolysis of chloramphenicol palmitate in presence of β-cyclodextrin
    • Berkel E., Mehnert W., Frömming K.-H. Enzymatic hydrolysis of chloramphenicol palmitate in presence of β-cyclodextrin. Pharmazie. 53:1998;323-326.
    • (1998) Pharmazie , vol.53 , pp. 323-326
    • Berkel, E.1    Mehnert, W.2    Frömming, K.-H.3
  • 2
    • 0035033241 scopus 로고    scopus 로고
    • Inhibition of cryptosporidium infection in mice treated with a cyclodextrin in inclusion complex with diloxanide furoate
    • Castro Hermida J.A., Ares-Mazás M.E., Nieto Reyes L., Otero Espinar F., Blanco Méndez J. Inhibition of cryptosporidium infection in mice treated with a cyclodextrin in inclusion complex with diloxanide furoate. Parasitol. Res. 87:2001;449-452.
    • (2001) Parasitol. Res. , vol.87 , pp. 449-452
    • Castro Hermida, J.A.1    Ares-Mazás, M.E.2    Nieto Reyes, L.3    Otero Espinar, F.4    Blanco Méndez, J.5
  • 3
    • 0031983473 scopus 로고    scopus 로고
    • Impact of opportunistic disease on survival in patients with HIV infection
    • Chaisson R.E., Gallant J.E., Keruly J.C., Moore R.D. Impact of opportunistic disease on survival in patients with HIV infection. AIDS. 12:1998;29-33.
    • (1998) AIDS , vol.12 , pp. 29-33
    • Chaisson, R.E.1    Gallant, J.E.2    Keruly, J.C.3    Moore, R.D.4
  • 4
    • 0033399882 scopus 로고    scopus 로고
    • Cristal structure of cyclomaltodecaose (ε-cyclodextrin) at 203 K
    • Endo T., Nagase H., Ueda H., Kobayashi S., Shiro M. Cristal structure of cyclomaltodecaose (ε-cyclodextrin) at 203 K. Anal. Sci. 15:1999;613-614.
    • (1999) Anal. Sci. , vol.15 , pp. 613-614
    • Endo, T.1    Nagase, H.2    Ueda, H.3    Kobayashi, S.4    Shiro, M.5
  • 5
    • 0033057186 scopus 로고    scopus 로고
    • α-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): Influence of pH, concentration and various cyclodextrins
    • Fredholt K., Ostergaard J., Friis G.J. α-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins. Int. J. Pharm. 178:1999;223-229.
    • (1999) Int. J. Pharm. , vol.178 , pp. 223-229
    • Fredholt, K.1    Ostergaard, J.2    Friis, G.J.3
  • 6
    • 0032471859 scopus 로고    scopus 로고
    • Water-borne cryptosporidiosis: Detection methods and treatment options
    • Fricker C.R., Crabb J.H. Water-borne cryptosporidiosis: detection methods and treatment options. Adv. Parasitol. 40:1998;241-278.
    • (1998) Adv. Parasitol. , vol.40 , pp. 241-278
    • Fricker, C.R.1    Crabb, J.H.2
  • 8
    • 0035543770 scopus 로고    scopus 로고
    • 10] LHRH ethylamide and hydroxy propyl β-cyclodextrin (HPβCD): Thermodynamics of interaction and protection from degradation by α-chymotrypsin
    • 10] LHRH ethylamide and hydroxy propyl β-cyclodextrin (HPβCD): thermodynamics of interaction and protection from degradation by α-chymotrypsin. Pharm. Dev. Technol. 6:2001;595-606.
    • (2001) Pharm. Dev. Technol. , vol.6 , pp. 595-606
    • Koushik, K.N.1    Bandi, N.2    Kompella, U.B.3
  • 9
    • 0038185084 scopus 로고    scopus 로고
    • The driving forces in the inclusion complexation of cyclodextrin
    • Liu L., Guo Q.X. The driving forces in the inclusion complexation of cyclodextrin. J. Incl. Phenom. Macrocyclic Chem. 42:2002;1-14.
    • (2002) J. Incl. Phenom. Macrocyclic Chem. , vol.42 , pp. 1-14
    • Liu, L.1    Guo, Q.X.2
  • 10
    • 0029819323 scopus 로고    scopus 로고
    • Pharmaceutical of cyclodextrins. 1. Drug solubilisation and stabilisation
    • Loftsson T., Brewster M.E. Pharmaceutical of cyclodextrins. 1. Drug solubilisation and stabilisation. J. Pharm. Sci. 85:1996;1017-1025.
    • (1996) J. Pharm. Sci. , vol.85 , pp. 1017-1025
    • Loftsson, T.1    Brewster, M.E.2
  • 11
    • 0030777456 scopus 로고    scopus 로고
    • Protection afforded by maltosyl-β-cyclodextrin against α-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate
    • Matsubara K., Ando Y., Irie T., Uekama K. Protection afforded by maltosyl-β-cyclodextrin against α-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate. Pharm. Res. 14:1997;1401-1405.
    • (1997) Pharm. Res. , vol.14 , pp. 1401-1405
    • Matsubara, K.1    Ando, Y.2    Irie, T.3    Uekama, K.4
  • 12
    • 0034147273 scopus 로고    scopus 로고
    • Effects of modified β-cyclodextrins on the hydrolysis reaction of p-nitrophenyl α-methoxyphenylacetate
    • Park J.W., Hong J.H., Park K.K. Effects of modified β-cyclodextrins on the hydrolysis reaction of p-nitrophenyl α-methoxyphenylacetate. J. Incl. Phenom. Macrocyclic Chem. 36:2000;343-354.
    • (2000) J. Incl. Phenom. Macrocyclic Chem. , vol.36 , pp. 343-354
    • Park, J.W.1    Hong, J.H.2    Park, K.K.3
  • 13
    • 0030713274 scopus 로고    scopus 로고
    • Criptosporidiosis in persons with HIV infection
    • Ramratnam B., Flanigan T.P. Criptosporidiosis in persons with HIV infection. Postgrat. Med. J. 73:1997;713-716.
    • (1997) Postgrat. Med. J. , vol.73 , pp. 713-716
    • Ramratnam, B.1    Flanigan, T.P.2
  • 14
    • 0343049206 scopus 로고    scopus 로고
    • Activation of serine protease subtilisin Carlsberg in organic solvents: Combined effect of methyl-β-cyclodextrin and water
    • Santos A.M., Clemente I.M., Barletta G., Griebenow K. Activation of serine protease subtilisin Carlsberg in organic solvents: combined effect of methyl-β-cyclodextrin and water. Biotechnol. Lett. 21:1999;1113-1118.
    • (1999) Biotechnol. Lett. , vol.21 , pp. 1113-1118
    • Santos, A.M.1    Clemente, I.M.2    Barletta, G.3    Griebenow, K.4
  • 15
    • 8244248457 scopus 로고    scopus 로고
    • Cyclodextins: Their future in drug formulation and delivery
    • Stella V.J., Rajewski R.A. Cyclodextins: their future in drug formulation and delivery. Pharm. Res. 14:1997;556-567.
    • (1997) Pharm. Res. , vol.14 , pp. 556-567
    • Stella, V.J.1    Rajewski, R.A.2
  • 16
    • 0001150192 scopus 로고
    • Physical properties and applications
    • Atwood, J.L., Davies, J.E.D., Mac Nicol, D.D. (Eds.). Academic Press, London
    • Szejtli, J., 1984. Physical properties and applications. In: Atwood, J.L., Davies, J.E.D., Mac Nicol, D.D. (Eds.), Inclusion Compounds, vol. 3. Academic Press, London.
    • (1984) Inclusion Compounds , vol.3
    • Szejtli, J.1
  • 17
    • 0002238956 scopus 로고
    • Cyclodextrins in pharmaceuticals
    • Kluwer Academic Publishers, Boston
    • Szejtli, J., 1988. Cyclodextrins in pharmaceuticals. In: Cyclodextrin Technology, Kluwer Academic Publishers, Boston. p. 236.
    • (1988) Cyclodextrin Technology , pp. 236
    • Szejtli, J.1
  • 18
    • 0025668492 scopus 로고
    • Cyclodextrins: Properties and applications
    • Szejtli J. Cyclodextrins: properties and applications. Drug Investig. 2:1990;11-21.
    • (1990) Drug Investig. , vol.2 , pp. 11-21
    • Szejtli, J.1
  • 19
    • 0034691643 scopus 로고    scopus 로고
    • Oral bioavailability and hypoglycaemic activity of tolbutamide/ cyclodextrin inclusion complexes
    • Veiga F., Fernandes C., Teixeira F. Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes. Int. J. Pharm. 202:2000;165-171.
    • (2000) Int. J. Pharm. , vol.202 , pp. 165-171
    • Veiga, F.1    Fernandes, C.2    Teixeira, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.